FASN expression correlates with poor prognosis in cutaneous melanoma [42], and inhibition of FASN reduces proliferation of B16–F10 melanoma cells in vitro [43] and reduces incidence of metastasis in vivo [44]. This evidence concerns the gene FASN and cutaneous melanoma.